Psoriatic Arthritis
From the Journals
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate
No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments...
Feature
Psoriasis, PsA, and pregnancy: Tailoring treatment with increasing data
Two experts give their up-to-date views on managing psoriasis and psoriatic arthritis before, during, and after pregnancy.
Feature
The long road to a PsA prevention trial
Researchers zero in on biologics, diet, and risk modeling to craft studies on a challenging population.
From the Journals
TNF inhibitors linked to inflammatory CNS events
The authors do not caution “against using these therapies in appropriate patients,” and it is unclear whether this association “represents de novo...
Latest News
Humira topped drug-revenue list for 2019
Three cytokine inhibitors were among the four best-selling drugs last year.
Conference Coverage
Beyond PASI 100: striving for molecular clearance
A PASI 100 response, traditionally considered unreachable for most patients with severe psoriasis, soon just might not be good enough.
Conference Coverage
Cohort study finds a twofold greater psoriasis risk linked to a PCOS diagnosis
Previous retrospective analyses have suggested an increased risk of psoriasis associated with polycystic ovarian syndrome.
From the Journals
New psoriasis guidelines focus on topical and alternative treatments, and severity measures
The latest updated psoriasis treatment guidelines address topicals, alternative medicine, and severity assessment.
Conference Coverage
Biologics may delay psoriatic arthritis, study finds
A single-center study shows reduced incidence in psoriatic arthritis in psoriasis patients treated with biologics.
Conference Coverage
New developments in pustular psoriasis
Genetic factors and novel therapies could chip away at this complex condition.
Conference Coverage
Psoriatic disease inflammation linked to heart failure
Psoriatic disease itself appears to contribute to heart failure risk rather than only comorbid cardiovascular risk factors.